Persones / Equip Humà

Cinzia Emilia Lavarino

Buscador de publicacions

Publicacions

  • Acosta S, Mayol G, Rodriguez E, Lavarino C, de Preter K, Kumps C, Garcia I, de Torres C and Mora J.

    Identification of tumoral glial precursor cells in neuroblastoma

    CANCER LETTERS . 312(1): 73-81. Nº de cites: 12

    [doi:10.1016/j.canlet.2011.08.004]

  • Garcia I, Mayol G, Rodriguez E, Suñol M, Gershon TR, Ríos J, Cheung NK, Kieran MW, George RE, Perez-Atayde AR, Casalà C, Galván P, de Torres C, Mora J and Lavarino C.

    Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma

    MOLECULAR CANCER . 9: 277-277. Nº de cites: 58

    [doi:10.1186/1476-4598-9-277]

  • De Preter K, Vermeulen J, Brors B, Delattre O, Eggert A, Fischer M, Janoueix-Lerosey I, Lavarino C, Maris JM, Mora J, Nakagawara A, Oberthuer A, Ohira M, Schleiermacher G, Schramm A, Schulte JH, Wang Q, Westermann F, Speleman F and Vandesompele J.

    Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature

    CLINICAL CANCER RESEARCH . 16(5): 1532-1541. Nº de cites: 76

    [doi:10.1158/1078-0432.CCR-09-2607]

  • de Torres C, Beleta H, Díaz-Naderi R, Toran N, Rodríguez E, Lavarino C, García I, Acosta S, Suñol M and Mora J.

    The Calcium-Sensing Receptor and Parathyroid Hormone-related Protein Are Expressed in Differentiated, Favorable Neuroblastic Tumors

    CANCER . 115(12): 2792-2803. Nº de cites: 24

    [doi:10.1002/cncr.24304]

  • Acosta S, Lavarino C, Paris R, Garcia I, de Torres C, Rodríguez E, Beleta H and Mora J.

    Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells

    BMC DEVELOPMENTAL BIOLOGY . 9: 12-12. Nº de cites: 50

    [doi:10.1186/1471-213X-9-12]

  • Lavarino C, Cheung NK, Garcia I, Domenech G, de Torres C, Alaminos M, Rios J, Gerald WL, Kushner B, LaQuaglia M and Mora J.

    Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma

    BMC Cancer . 9: 44-44. Nº de cites: 27

    [doi:10.1186/1471-2407-9-44]

  • Lavarino C, Garcia I, Mackintosh C, Cheung NK, Domenech G, Ríos J, Perez N, Rodríguez E, de Torres C, Gerald WL, Tuset E, Acosta S, Beleta H, de Alava E and Mora J.

    Differential expression of genes mapping to recurrently abnormal chromosomal regions characterize neuroblastic tumours with distinct ploidy status

    BMC MEDICAL GENOMICS . 1: 36-36. Nº de cites: 11

    [doi:10.1186/1755-8794-1-36]

  • Mora J, Lavarino C, Alaminos M, Cheung NK, Ríos J, de Torres C, Illei P, Juan G and Gerald WL.

    Comprehensive analysis of tumoral DNA content reveals clonal ploidy heterogeneity as a marker with prognostic significance in locoregional neuroblastoma

    GENES CHROMOSOMES & CANCER . 46(4): 385-396. Nº de cites: 7

    [doi:10.1002/gcc.20421]

  • Coma S, Noe V, Lavarino C, Adán J, Rivas M, López-Matas M, Pagan R, Mitjans F, Vilaró S, Piulats J and Ciudad CJ.

    Use of siRNAs and antisense oligonucleotides against survivin RNA to inhibit steps leading to tumor angiogenesis.

    Oligonucleotides . 14(2): 100-113. Nº de cites: 58

    [doi:10.1089/1545457041526290]

  • Tamborini E, Della Torre G, Lavarino C, Azzarelli A, Carpinelli P, Pierotti MA and Pilotti S.

    Analysis of the molecular species generated by MDM2 gene amplification in liposarcomas.

    INTERNATIONAL JOURNAL OF CANCER . 92(6): 790-796. Nº de cites: 43

    [doi:10.1002/ijc.1271]